Answers are grounded in this paper and cite their sources.
Theiler’s murine encephalomyelitis virus (TMEV) represents a well-established experimental model for the progressive form of multiple sclerosis in susceptible SJL mice. In contrast, resistant C57BL/6 mice are able to completely clear the virus. Our previous data showed that OT-I mice on a resistant C57BL/6-background, which express an MHC-I-restricted T cell receptor specific for the chicken ovalbumin, are rendered susceptible to experimental intracerebral infection with TMEV. They also showed viral spread into the spinal cord due to an impaired T cell response. Because CD8 + T cells substantially contribute to anti-viral adaptive immune responses, we investigated whether an adoptive transfer of CD8 + T cells with a fully functional T cell receptor repertoire may modify the disease course of TMEV in OT-I mice regarding clinical progression and pathological manifestation. We assessed clinical progression and histomorphologic changes, evaluated T cell activation and migration by flow cytometry, and performed neurofilament light chain serum analysis. Viral load was quantified by immunohistochemistry and gene expression by RNA sequencing. Transfer of 5 × 10 6 CD8 + T cells into TMEV-infected OT-I mice attenuated clinical progression, significantly increased survival, and reduced clinical score, viral load, and inflammatory score. Flow cytometry revealed that transferred red fluorescent protein -CD8 + T cells constituted the majority of activated/effectorCD8 + T cells in the brain, and RNA sequencing confirmed the enhancement of an ongoing adaptive immune response. However, a complete rescue and long-term survival of TMEV-infected OT-I mice could not be achieved.
No takes yet. Share an insight, caveat, or question.
Segna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: